Impact of Therapeutic Osteopathy-hypnosis on Cancer Patients.
RecruitingNot applicableNCT07860476
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Osteopathy is recognized as a beneficial complementary approach for cancer patients. By addressing tissue mobility, circulation, and muscle tension, it helps improve physical comfort, reduce musculoskeletal pain, and foster better functional recovery. Several studies have shown that osteopathy can help reduce pain intensity and improve the quality of life for patients undergoing cancer treatment. Combining hypnosis with osteopathy could thus optimize treatment outcomes by integrating a holistic approach that addresses both physical and psychological needs. The aim of this study is to evaluate the impact of combined osteopathy and hypnosis treatment compared to osteopathic treatment alone in cancer patients, particularly regarding pain with a strong emotional component.
Study details
- Official title
- Functional and Psychological Evaluation of Combined Osteopathy and Therapeutic Hypnosis in Cancer Patients Living With Chronic Pain: a Randomized Study Comparing Osteopathy and Hypnosis With Osteopathy Alone.
- Conditions
- Interventions
- Behavioral: Osteopathy
- Behavioral: Hypnosis
- Sponsor
- Institut Rafael
- Collaborators
- Hartmann Oncology Radiotherapy Group, France
- Start date
- 2026-09-30
- Primary completion
- 2027-09
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years, * Patient diagnosed with cancer (currently undergoing treatment or having completed oncological treatment), * Experiencing chronic pain (≥ 3 months), * Presenting a strong emotional component to the pain: K10 score between 20 and 29, * Patient able to attend all visits and follow study procedures, * Patient who has provided consent. Exclusion Criteria: * Patients with no emotional distress or with severe distress * Sensory (auditory, visual) or cognitive deficits likely to hinder the conduct of hypnosis sessions * Patient who has undergone hypnotherapy sessions within the last 3 months * Patient unable to provide consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07860476